ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2019 American Transplant Congress

    The Value of SCS Perfusate Biomarkers for Predicting DGF of DCD Donor Kidneys

    X. Li, W. Wang, X. Zhang

    Beijing Chaoyang Hospital, Capital Medical University, Beijing, China

    *Purpose: To explore the possibilities of simple cold stored(SCS) perfusate biomarkers predicting delayed graft function(DGF) in donor of cardiac death (DCD) kidneys.*Methods: A total of…
  • 2019 American Transplant Congress

    Chemokine Ligand 14 is a Novel Therapeutic Target in Kidney Fibrosis

    S. Lee1, Y. Kim1, J. Moon1, H. Lee1, S. Han1, J. Lee2, R. Cha3, D. Kim1, C. Lee4, K. Kim5, Y. Kim1, S. Yang6

    1Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of, 2Internal Medicine, Boramae Medical Center, Seoul, Korea, Republic of, 3Internal Medicine, National Medical Center, Seoul, Korea, Republic of, 4Internal Medicine, Cheju Halla University Hospital, Jeju, Korea, Republic of, 5Biomedical Science, Seoul National University, Seoul, Korea, Republic of, 6Seoul National University College of Medicine, Seoul, Korea, Republic of

    *Purpose: Chemokine ligand 14 (CCL14), a ligand for CCR1, has been known as a M2 polarizing marker and chemotactic cytokine, which is expressed by fibroblast,…
  • 2019 American Transplant Congress

    Outcome Of Late Biopsy-negative Rejection After Heart Transplantation

    M. Kittleson, J. Patel, E. Kransdorf, S. Dimbil, R. Levine, J. A. Kobashigawa

    Cedars-Sinai Smidt Heart Institute, Los Angeles, CA

    *Purpose: Biopsy-negative rejection (BNR) is an entity where the endomyocardial biopsy (EMB) shows no findings of rejection, but there is proven cardiac dysfunction i.e. low…
  • 2019 American Transplant Congress

    Outcome Of Left Main Stenting After Heart Transplantation

    S. Dimbil, J. Patel, B. Azarbal, M. Kittleson, R. Levine, D. H. Chang, J. A. Kobashigawa

    Cedars-Sinai Smidt Heart Institute, Los Angeles, CA

    *Purpose: Cardiac allograft vasculopathy (CAV) is one of the major factors limiting long-term survival after HTx. The use of angioplasty and drug-eluting stents is common…
  • 2019 American Transplant Congress

    Intravenous Methamphetamine Does Not Appear To Be A Contraindication For Heart Donation In Heart Transplantation

    A. Velleca, J. Patel, M. Kittleson, R. Levine, S. Dimbil, S. Mersola, M. Hamilton, F. Esmailian, J. A. Kobashigawa

    Cedars-Sinai Smidt Heart Institute, Los Angeles, CA

    *Purpose: Intravenous methamphetamine (IV meth) use in potential heart donors has been of concern due to the possibility of methamphetamine cardiomyopathy and transmission of infections.…
  • 2019 American Transplant Congress

    Impact of Donor Acute Kidney Injury on the Outcome of Graft Delayed Graft Function

    C. Jadlowiec, A. Kumar, A. Srinivasan, A. Mathur, M. Smith, J. Huskey, A. Moss, H. Khamash, R. L. Heilman, K. S. Reddy

    Mayo Clinic, Phoenix, AZ

    *Purpose: Kidneys from deceased donors with acute kidney injury (AKI) have a higher risk of delayed graft function (DGF). The aim of this study was…
  • 2019 American Transplant Congress

    Can National Data Predict Which Older Kidney Donors Are More Likely to Yield Higher eGFR 1-Year Post-Transplant?

    C. A. Custer1, R. J. Carrico1, T. L. Pruett2

    1United Network for Organ Sharing, Richmond, VA, 2University of Minnesota, Minneapolis, MN

    *Purpose: Older donors (65+) have been utilized at low rates despite accounting for the majority of deaths in the U.S. (73%, CDC). Kasiske et al.…
  • 2019 American Transplant Congress

    Evaluation of Pretransplant Biopsy as a Influence Factor of Early Graft Function after Donated Kidney Transplantation

    X. Qiuxiang, W. Zhendi

    Urology Surgery, Wuhan Union Hospital, Wuhan, China

    *Purpose: To investigate the relationship between pretransplant biopsy and the early graft function after donated kidney transplantation.*Methods: We examined pretransplant biopsies for 240 kidney transplant…
  • 2019 American Transplant Congress

    Efficacy Of Rituximab Monotherapy On Anti-human Leukocyte Antigen Antibodies In Highly Sensitized Living Donor Kidney Transplant Patients.

    D. J. Sindi1, A. Al Jedai2, H. Aleid3, J. Brockmann4, M. Al-Awwami5, D. Alissa2, E. De Vol6, H. Al Khabbaz7, L. Fajji8

    1Clinical Pharmacy, King Faisal Specialist Hospital and Research Center (KFSH&RC), Riyadh, Saudi Arabia, 2Clinical Pharmacy, KFSH&RC, Riyadh, Saudi Arabia, 3Kidney and Pancreas transplantation, KFSH&RC, Riyadh, Saudi Arabia, 4kFSH&RC, Riyadh, Saudi Arabia, 5Clinical Director, Histocompatibility and Immunogenetics Laboratory, KFSH&RC, Riyadh, Saudi Arabia, 6KFSH&RC, Riyadh, Saudi Arabia, 7Riyadh Elm University, Riyadh, Saudi Arabia, 8Clinical Transplant Coordinator, KFSH&RC, Riyadh, Saudi Arabia

    *Purpose: We aim to examine the efficacy of Rituximab (RTX) monotherapy in reducing DSA in Highly Sensitised Living Donor Kidney Transplant (HS-LDKT) candidates and potentially…
  • 2019 American Transplant Congress

    Outcomes of Reduced Thymoglobulin Induction Dosing in Elderly Kidney Transplant Recipients at a Steroid Sparing Center

    E. C. Liu, J. H. Lee, R. Abramova

    Pharmacy, NewYork-Presbyterian, New York, NY

    *Purpose: Studies have demonstrated a mortality benefit with kidney transplantation (KT) in elderly patients, but there is little consensus over optimal immunosuppression. Older KT recipients…
  • « Previous Page
  • 1
  • …
  • 108
  • 109
  • 110
  • 111
  • 112
  • …
  • 214
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences